Biomedical Innovation May Get Fresh Boost From House Duo

July 10, 2019, 7:54 PM

New biomedical innovation legislation is in the works from the bipartisan pair behind the 21st Century Cures Act, the massive 2016 law aiming at spurring new drugs and devices.

Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo.) said in a joint statement issued July 10, exactly four years after the House passed the Cures legislation (Pub. L. 114-255), that they are “beginning to work on new bipartisan legislation that will continue to build upon the progress we have made and help us take the next step toward finding even more life-saving cures.”

Their statement was short on ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.